×
Maintenance Notice:
You may experience temporary website slowness while maintenance is being performed. Thank you for your patience.
We recently upgraded the website!  If you run into any issues, please Contact Us.   Enjoy exploring the new site!

Twin Cities Chapter In Person Event- Biocompatibility Essentials for Medical Devices

A practical session on biological evaluation of medical devices: ISO 10993, US FDA & EU MDR expectations, and chemical characterization. Hosted by TUV SUD with Medtronic.

Twin Cities Chapter In Person Event- Biocompatibility Essentials for Medical Devices: From ISO 10993 to US and EU Regulatory Expectations

Join the RAPS Twin Cities Chapter for a practical, collaborative session on the biological evaluation of medical devices hosted by TÜV SÜD in partnership with Medtronic. Bringing together regulatory, toxicology, and testing-lab perspectives, this event is designed to help regulatory professionals confidently plan, interpret, and defend the biocompatibility evidence used to support device safety across global markets.

Through real-world examples and expert dialogue, attendees will explore how the ISO 10993 framework is applied in practice, how US (FDA) and EU (MDR) expectations differ, and how chemical characterization and toxicological risk assessment are reshaping biological evaluation. The session emphasizes clarity, regulatory relevance, and effective cross-functional communication between regulatory, R&D, and testing partners.

Learning Objectives

By the end of this session, participants will be able to:

  • Apply a risk-based approach to biological evaluation using the ISO 10993-1 framework and biological evaluation plan (BEP)
  • Compare key U.S. and EU regulatory expectations for biocompatibility, including FDA guidance and EU MDR considerations
  • Describe how chemical characterization and toxicological risk assessment (ISO 10993-18 / -17) support or reduce animal testing
  • Understand key concepts and common areas of regulatory concern in biological evaluation, such as:
    • Selection of biological endpoints and test article preparation
    • Use of chemical characterization data in lieu of biological testing
    • Justifying gaps, equivalence, and use of existing data

Why Should You Attend?

  • Understand how the ISO 10993 family of standards structures a risk-based biological evaluation
  • Gain insight into current U.S. and EU approaches to biocompatibility evaluations
  • Learn how US (FDA) and EU (MDR) expectations for biocompatibility differ — and where they align
  • See how chemical characterization (extractables & leachables) and toxicological risk assessment fit into a modern evaluation strategy
  • Recognize common gaps that lead to regulatory questions or deficiencies
  • Gain insight into the role and capabilities of an accredited biocompatibility testing laboratory
  • Improve confidence when discussing biological safety with toxicology, testing, and regulatory stakeholders

Who Should Attend?

This session is designed for:

  • Regulatory affairs professionals (all levels)
  • Quality, R&D, and design assurance partners
  • Toxicologists and biocompatibility / biological evaluation specialists
  • Testing, chemistry, and materials engineering partners
  • Anyone involved in generating, interpreting, or defending biocompatibility evidence for medical devices

Agenda

1:00 – 1:30 PM

Welcome, Check-in & Introductions
Registration and networking

1:30 – 1:35 PM Welcome & Opening Remarks
Introduction by Tom Brumbaugh (TÜV SÜD)
RAPS Twin Cities Chapter welcome to members
1:35 – 2:20 PM

Session 1 — ISO 10993-1 Updates
Risk-based approach to biological evaluation
Panel contribution: industry perspective

2:20 – 3:05 PM

Session 2 — US and EU Expectations on Biocompatibility
Regulatory expectations in the U.S. and Europe
Considerations for supporting global market access

3:05 – 3:20 PM Break
3:20 – 4:05 PM

Session 3 — Best Practices for E&L / Chemical Characterization
Extractables & leachables considerations (ISO 10993-18)
Reducing animal testing through chemistry-based approaches

4:05 – 5:00 PM

Panel Discussion, Q&A and Closing Remarks
Cross-functional dialogue with speakers and attendees

5:00 PM onward

Optional Lab Tour
Guided tour of the TÜV SÜD biocompatibility, chemistry, and microbiology laboratories

Location

TÜV SÜD New Brighton Laboratory
141 14th St NW
New Brighton, MN 55112

Cancellations and Refunds

RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.

Substitutions

Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.

Proof of Attendance

A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.

Questions

Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected]  

Speakers

Thomas (Tom)  Brumbaugh

Thomas (Tom) Brumbaugh

Medical Device Testing Manager, TÜV SÜD

Find out more

Steph M.  Street PhD

Steph M. Street PhD

Senior Principal Toxicologist and Biocompatibility SME · Technical Fellow, Medtronic

Find out more

Lindsey K.  Borton

Lindsey K. Borton

M.P.H., DABT, Principal , Gradient

Find out more

Sonja  Gunderson

Sonja Gunderson

Senior Chemist, TÜV SÜD

Find out more

Cedric  Jimenez

Cedric Jimenez

Senior Extraction Specialist, TÜV SÜD

Find out more